MONTREAL, March 20, 2020 /PRNewswire/ – (NYSE: CAE) (TSX: CAE) – RBC Capital Markets will host a conference call with CAE’s leadership team on Monday, March 23 at 11 a.m. EDT. Marc Parent, CAE’s President and Chief Executive Officer, Sonya Branco, CAE’s Chief Financial Officer, and Andrew Arnovitz, CAE’s Vice President, Strategy and Investor Relations, will participate on this call, which will be moderated by Steve Arthur, Equity Analyst at RBC Capital Markets.
The session is intended to provide insights on the potential impact of the rapidly evolving COVID-19 situation, along with mitigating actions being implemented. The discussion will focus on the resiliency of CAE’s business model, balance sheet status and flexibility, as well as operational and financial measures being taken across CAE, during these unprecedented times.
The meeting will be webcast live at this address : https://www.veracast.com/webcasts/rbc/meetings/5zfdM1kv.cfm
Shortly after the session, the replay will be available on CAE’s website until March 30.
|
Event: |
In conversation with CAE management: Navigating through unprecedented times |
|
Date: |
Monday, March 23, 2020 |
|
Time: |
11 a.m. ET |
About CAE
CAE is a global leader in training for the civil aviation, defense and security, and healthcare markets. Backed by a record of more than 70 years of industry firsts, we continue to help define global training standards with our innovative virtual-to-live training solutions to make flying safer, maintain defense force readiness and enhance patient safety. We have the broadest global presence in the industry, with over 10,000 employees, 160 sites and training locations in over 35 countries. Each year, we train more than 220,000 civil and defense crewmembers, including more than 135,000 pilots, and thousands of healthcare professionals worldwide. www.cae.com
Follow us on Twitter @CAE_Inc
View original content:http://www.prnewswire.com/news-releases/cae-invited-to-take-part-in-rbc-moderated-webcast-about-the-covid-19-situation-and-its-impact-301027775.html
SOURCE CAE INC.
The DEA was created to combat cartel trafficking, protect public health, and ensure researchers have…
CAMBRIDGE, Mass., Dec. 07, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology…
Longer-term analyses reinforce duvelisib’s activity across treatment-experienced PTCL populations, including patients with ≥3 prior lines…
- Combination of evorpacept plus rituximab and lenalidomide (R2) generated complete responses (CR) in 92%…
Media ReleaseCOPENHAGEN, Denmark; December 7, 2025 Trial demonstrated treatment with fixed duration EPKINLY plus rituximab…
― Clear dose-response observed, with a robust and clinically meaningful fetal hemoglobin (HbF) induction at…